# Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study

> **NCT06225232** · PHASE2 · RECRUITING · sponsor: **McMaster University** · enrollment: 16 (estimated)

## Conditions studied

- Cannabis Use Disorder, Moderate
- Cannabis Use Disorder, Severe

## Interventions

- **DRUG:** Psilocybin combined with Psychotherapy

## Key facts

- **NCT ID:** NCT06225232
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2026-03
- **Final completion:** 2026-06
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06225232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06225232, "Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06225232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*